MarketsandMarkets Conferences Blogs
Undeniably so, almost every aspect of our lives is seemingly attached to a form of technology which over the past decade has grown to a level of importance occupied only by necessities like food & water. Advancements have allowed us to harness the power of technology for betterment of our livelihoods, unimaginable lengths of communication […]
Technological advancements have greatly transformed medicine & the healthcare industry by bridging the gap between ideation of innovative techniques and its eventual, physical execution. One such niche which has benefited & developed parallelly is known as Minimally Invasive Surgery (MIS). Procedures such as Arthroscopy, Endoscopy, Laparoscopy & robotic surgeries are the most common forms of […]
Over the past 2 decades, immense research and development occurred surrounding the Human Microbiome Project to gain deeper insights on the microorganisms that reside within the human body, especially our gut. Often referred to as a ‘supporting organ’, the collection of bacteria, fungi & viruses to whom we play host, is more commonly known as […]
The 3rd Annual MarketsandMarkets Single Cell Analysis Conference kicks off at the Hyatt Regency Boston/Cambridge on the 23rd & 24th of June 2022. With 100+ attendees & stellar presentations from over 15+ industry experts and leaders, the countdown has well & truly begun. As we look forward to the hosting you in person, our keynote […]
Just over 3 weeks remain until the 3rd Annual MarketsandMarkets Single Cell Analysis Conference kicks off at the Hyatt Regency Boston/Cambridge on the 23rd & 24th of June 2022. With 100+ attendees & stellar presentations from over 15+ industry experts and leaders, we’re counting down the days till we can finally host you in person! […]
Prior to and only enhanced by the pandemic, in vitro analysis of biological specimens like tissue samples or blood amongst others plays a huge role in guiding accurate diagnosis & subsequent therapy. When used in tandem with a specific therapeutic drug or medicine and relying on the presence or absence of a predictive biomarker, such […]
The pandemic served up some stark reminders of our visibly fragile mortality. Over the course of two years, Covid-19 ravaged humanity and yet it did leave behind silver linings.Epidemic & global pandemic preparedness increased tenfold. Technological innovations were integrated sooner & the healthcare ecosystem worked in overdrive, accelerating its development of crucial vaccines. More importantly […]
With just over a month till the MarketsandMarkets BioPharma Series kicks off in Boston on the 23rd & 24th of June 2022, we believed it would be apt to unveil a glimpse of the enriching insights our esteemed speakers shall be bringing to the tri-conference event. On the eve of our 3rd Annual MarketsandMarkets Single-Cell […]
Post the turn of the century, unchecked plundering of our limited fossil fuels & natural gas reserves has driven humanity to the fragile precipice it stands on today. Heatwaves have gone from freak phenomena to a regular occurrence around the globe. AQI’s of major cities & international business hubs continue to decline in quality as […]
For as long as medicine has existed, cancers have ravaged humanity. The search for an eventual cure has been a tremendous & tireless pursuit, selflessly undertaken by doctors, researchers, scientists & the entire healthcare community. With each passing year and the availability of sophisticated technologies, their efforts continue to go from strength to strength, expanding […]
